Fabry L, Roberfroid M
Toxicol Lett. 1981 Jan;7(3):245-50. doi: 10.1016/0378-4274(81)90076-x.
Aflatoxin B1 (AFB1) was shown to be clastogenic in vivo on the basis of its capacity to produce micronucleated cells and chromosomal aberrations in mouse bone marrow cells. On the other hand, in vitro studies on cultured human lymphocytes suggested only a slight mutagenic action of AFB1. If, however, a microsomal extract isolated from rat liver was added together with the AFB1 (1.92 X 10(-5) M) to the lymphocytes before the incubation period, the yield of chromosomal aberrations and of sister chromatid exchanges (SCE) increased markedly indicating that AFB1 must be metabolically converted before it can act as an active mutagen. The use of microsomal extracts for in vitro tests can thus considerably improve the reliability of such tests of mutagenicity although studies in vitro will not be able to entirely replace those in vitro.
黄曲霉毒素B1(AFB1)因其能够在小鼠骨髓细胞中产生微核细胞和染色体畸变,在体内表现出致断裂性。另一方面,对培养的人淋巴细胞的体外研究表明,AFB1只有轻微的诱变作用。然而,如果在潜伏期前将从大鼠肝脏分离的微粒体提取物与AFB1(1.92×10⁻⁵M)一起加入淋巴细胞中,染色体畸变和姐妹染色单体交换(SCE)的发生率会显著增加,这表明AFB1在能够作为活性诱变剂起作用之前必须进行代谢转化。因此,使用微粒体提取物进行体外试验可以大大提高此类诱变性试验的可靠性,尽管体外研究不能完全取代体内研究。